Novartis AG reported a 2% increase in sales and a 4% rise in operating profit for the third 2017 quarter while maintaining its forecast of little change in sales for the year and possibly a decline in operating profit. Over nine months, sales were about unchanged at $36.2 billion while operating profit dipped 4% to $6.56 billion.
